BODI: the cashflow

MyFinsight

For the quarter ending 2025-09-30, BODI had $8,388K increase in cash & cash equivalents over the period. $9,000K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	3,569	-11,648
Depreciation and amortization expense	1,879	4,910
Amortization of content assets	1,927	5,018
Provision for inventory	1,256	-
Realized losses on hedging derivative financial instruments	0	0
Change in fair value of warrant liabilities	762	-869
Deferred income taxes	-	0
Equity-based compensation	1,003	3,741
Amortization of debt issuance costs	161	1,119
Paid-in-kind interest expense	0	218
Loss on debt extinguishment	0	-2,166
Change in lease assets	638	523
Inventory	441	-4,340
Provision for inventory	-	559
Content assets	1,004	1,290
Prepaid expenses	-370	-4,348
Other assets	-4,881	-18,497
Accounts payable	-587	-4,647
Accrued expenses	3,062	-4,906
Deferred revenue	-5,074	-12,360
Other liabilities	-1,656	-3,139
Net cash provided by operating activities	10,187	6,580
Purchase of property and equipment	1,187	2,511
Net cash (used in) provided by investing activities	-1,187	-2,511
Proceeds from exercise of stock options	20	47
Debt borrowings	0	25,000
Debt repayments	0	22,582
Proceeds from issuance of common shares in the employee stock purchase plan	0	78
Tax withholding payments for vesting of restricted stock	56	215
Payment of debt issuance costs	238	1,543
Net cash provided by (used in) financing activities	-274	785
Effect of exchange rates on cash, cash equivalents, and restricted cash	-338	520
Net increase (decrease) in cash, cash equivalents, and restricted cash	8,388	5,374
Cash and cash equivalents at beginning of period	20,187	-
Cash and cash equivalents at end of period	33,949	-

Unit: Thousand (K) dollars